Fingerprint
Dive into the research topics of 'ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial
Jeffrey A. Lieberman, Robert E. Davis, Christoph U. Correll, Donald C. Goff, John M. Kane, Carol A. Tamminga, Sharon Mates, Kimberly E. Vanover
Research output: Contribution to journal › Article › peer-review
62
Scopus
citations